# Exempt Chemical Preparations Under the Controlled Substances Act > Briefs, arguments, decisions, and more. URL: https://www.frixlaw.com/law-library/documents/fr%3A2021-06689 ## Record - **Collection:** Federal Register - **Document type:** Notice - **Published:** April 23, 2021 - **Citation:** 86 FR 21814 ## Text DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-372] Exempt Chemical Preparations Under the Controlled Substances Act AGENCY: Drug Enforcement Administration, Department of Justice. ACTION: Order with opportunity for comment. SUMMARY: The applications for exempt chemical preparations received by the Drug Enforcement Administration (DEA) between July 1, 2018, and December 31, 2020, as listed below, were accepted for filing and have been approved or denied as indicated. DATES: Interested persons may file written comments on this order in accordance with 21 CFR 1308.23(e). Electronic comments must be submitted, and written comments must be postmarked, on or before June 22, 2021. Commenters should be aware that the electronic Federal Docket Management System will not accept comments after 11:59 p.m. Eastern Time on the last day of the comment period. ADDRESSES: To ensure proper handling of comments, please reference “Docket No. DEA-372” on all correspondence, including any attachments. Electronic comments: DEA encourages that all comments be submitted through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or to attach a file for lengthier comments. Please go to http://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon completion of your submission you will receive a Comment Tracking Number for your comment. Please be aware that submitted comments are not instantaneously available for public view on Regulations.gov. If you have received a comment tracking number, your comment has been successfully submitted and there is no need to resubmit the same comment. Paper comments: Paper comments that duplicate the electronic submission are not necessary and are discouraged. Should you wish to mail a comment in lieu of an electronic comment, it should be sent via regular or express mail to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DRW, 8701 Morrissette Drive, Springfield, Virginia 22152. FOR FURTHER INFORMATION CONTACT: Terrence L. Boos, Ph.D., Diversion Control Division, Drug Enforcement Administration; Telephone: (571) 362-8201. SUPPLEMENTARY INFORMATION: Posting of Public Comments Please note that all comments received are considered part of the public record and made available for public inspection online at http://www.regulations.gov and in the DEA's public docket. Such information includes personal identifying information (such as your name, address, etc.) voluntarily submitted by the commenter. The Freedom of Information Act applies to all comments received. If you want to submit personal identifying information (such as your name, address, etc.) as part of your comment, but do not want it to be posted online or made available in the public docket, you must include the phrase “PERSONAL IDENTIFYING INFORMATION” in the first paragraph of your comment. You must also place all the personal identifying information you do not want posted online or made available in the public docket in the first paragraph of your comment and identify what information you want redacted. If you want to submit confidential business information as part of your comment, but do not want it to be posted online or made available in the public docket, you must include the phrase “CONFIDENTIAL BUSINESS INFORMATION” in the first paragraph of your comment. You must also prominently identify confidential business information to be redacted within the comment. Comments containing personal identifying information and confidential business information identified as directed above will generally be made publicly available in redacted form. If a comment has so much confidential business information that it cannot be effectively redacted, all or part of that comment may not be made publicly available. Comments posted to http://www.regulations.gov may include any personal identifying information (such as name, address, and phone number) included in the text of your electronic submission that is not identified as directed above as confidential. An electronic copy of this document is available at http://www.regulations.gov for easy reference. Legal Authority Section 201 of the Controlled Substances Act (CSA) (21 U.S.C. 811) authorizes the Attorney General, by regulation, to exempt from certain provisions of the CSA certain compounds, mixtures, or preparations containing a controlled substance, if he finds that such compounds, mixtures, or preparations meet the requirements detailed in 21 U.S.C. 811(g)(3)(B). 1 The DEA regulations at 21 CFR 1308.23 and 1308.24 further detail the criteria by which the DEA Assistant Administrator may exempt a chemical preparation or mixture from certain provisions of the CSA. The Assistant Administrator may, pursuant to 21 CFR 1308.23(f), modify or revoke the criteria by which exemptions are granted and modify the scope of exemptions at any time. 1 This authority has been delegated from the Attorney General to the Administrator of the DEA by 28 CFR 0.100, and subsequently redelegated to the Deputy Assistant Administrator pursuant to 28 CFR 0.104 and Section 7 of the appendix to subpart R of part 0. Exempt Chemical Preparation Applications Submitted Between July 1, 2018, and December 31, 2020 The Assistant Administrator received applications between July 1, 2018, and December 31, 2020, requesting exempt chemical preparation status detailed in 21 CFR 1308.23. Pursuant to the criteria stated in 21 U.S.C. 811(g)(3)(B) and in 21 CFR 1308.23, the Assistant Administrator has found that each of the compounds, mixtures, and preparations described in Chart I below is intended for laboratory, industrial, educational, or special research purposes and not for general administration to a human being or animal and either: (1) Contains no narcotic controlled substance and is packaged in such a form or concentration that the packaged quantity does not present any significant potential for abuse; or (2) contains either a narcotic or non-narcotic controlled substance and one or more adulterating or denaturing agents in such a manner, combination, quantity, proportion, or concentration that the preparation or mixture does not present any potential for abuse and, if the preparation or mixture contains a narcotic controlled substance, is formulated in such a manner that it incorporates methods of denaturing or other means so that the preparation or mixture is not liable to be abused or have ill effects, if abused, and so that the narcotic substance cannot in practice be removed. Accordingly, pursuant to 21 U.S.C. 811(g)(3)(B), 21 CFR 1308.23, and 21 CFR 1308.24, the Assistant Administrator has determined that each of the chemical preparations or mixtures generally described in Chart I below and specifically described in the application materials received by DEA is exempt, to the extent described in 21 CFR 1308.24, from application of sections 302, 303, 305, 306, 307, 308, 309, 1002, 1003, and 1004 (21 U.S.C. 822-823, 825-829, and 952-954) of the CSA, and 21 CFR 1301.74, as of the date that was provided in the approval letters to the individual requesters. Scope of Approval The exemptions are applicable only to the precise preparation or mixture described in the application submitted to DEA in the form(s) listed in this order and only for those above mentioned sections of the CSA and the CFR. In accordance with 21 CFR 1308.24(h), any change in the quantitative or qualitative composition of the preparation or mixture, or change in the trade name or other designation of the preparation or mixture after the date of application requires a new application. The requirements set forth in 21 CFR 1308.24(b)-(e) apply to the exempted materials. In accordance with 21 CFR 1308.24(g), DEA may prescribe requirements other than those set forth in 21 CFR 1308.24(b)-(e) on a case-by-case basis for materials exempted in bulk quantities. Accordingly, in order to limit opportunity for diversion from the larger bulk quantities, DEA has determined that each of the exempted bulk products listed in this order may only be used in-house by the manufacturer, and may not be distributed for any purpose, or transported to other facilities. Additional exempt chemical preparation requests received between July 1, 2018, and December 31, 2020, and not otherwise referenced in this order, may remain under consideration until DEA receives additional information required, pursuant to 21 CFR 1308.23(d), as detailed in separate correspondence to individual requesters. DEA's order on such requests will be communicated to the public in a future Federal Register publication. DEA also notes that these exemptions are limited to exemption from only those sections of the CSA and the CFR that are specifically identified in 21 CFR 1308.24(a). All other requirements of the CSA and the CFR apply, including registration as an importer as required by 21 U.S.C. 957. BILLING CODE 4410-09-P EN23AP21.001 EN23AP21.002 EN23AP21.003 EN23AP21.004 EN23AP21.005 EN23AP21.006 EN23AP21.007 EN23AP21.008 EN23AP21.009 EN23AP21.010 EN23AP21.011 EN23AP21.012 EN23AP21.013 EN23AP21.014 EN23AP21.015 EN23AP21.016 EN23AP21.017 EN23AP21.018 EN23AP21.019 EN23AP21.020 EN23AP21.021 EN23AP21.022 EN23AP21.023 EN23AP21.024 EN23AP21.025 EN23AP21.026 EN23AP21.027 EN23AP21.028 EN23AP21.029 EN23AP21.030 EN23AP21.031 EN23AP21.032 EN23AP21.033 EN23AP21.034 EN23AP21.035 EN23AP21.036 EN23AP21.037 EN23AP21.038 EN23AP21.039 EN23AP21.040 EN23AP21.041 EN23AP21.042 EN23AP21.043 EN23AP21.044 EN23AP21.045 EN23AP21.046 EN23AP21.047 EN23AP21.048 EN23AP21.049 EN23AP21.050 EN23AP21.051 EN23AP21.052 EN23AP21.053 EN23AP21.054 EN23AP21.055 EN23AP21.056 EN23AP21.057 EN23AP21.058 EN23AP21.059 EN23AP21.060 EN23AP21.061 EN23AP21.062 EN23AP21.063 EN23AP21.064 EN23AP21.065 EN23AP21.066 EN23AP21.067 EN23AP21.068 EN23AP21.069 EN23AP21.070 EN23AP21.071 EN23AP21.072 EN23AP21.073 EN23AP21.074 EN23AP21.075 EN23AP21.076 EN23AP21.077 EN23AP21.078 EN23AP21.079 EN23AP21.080 EN23AP21.081 EN23AP21.082 EN23AP21.083 EN23AP21.084 EN23AP21.085 EN23AP21.086 EN23AP21.087 EN23AP21.088 EN23AP21.089 EN23AP21.090 EN23AP21.091 EN23AP21.092 EN23AP21.093 EN23AP21.094 EN23AP21.095 EN23AP21.099 Opportunity for Comment Pursuant to 21 CFR 1308.23(e), any interested person may submit written comments on or objections to any chemical preparation in this order that has been approved or denied as exempt. If any comments or objections raise significant issues regarding any finding of fact or conclusion of law upon which this order is based, the Assistant Administrator will immediately suspend the effectiveness of any applicable part of this order until he may reconsider the application in light of the comments and objections filed. Thereafter, the Assistant Administrator shall reinstate, revoke, or amend his original order as he determines appropriate. Approved Exempt Chemical Preparations Are Posted on the DEA's Website A list of all current exemptions, including those listed in this order, is available on the DEA's website at http://www.DEAdiversion.usdoj.gov/schedules/exempt/exempt_chemlist.pdf. The dates of applications of all current exemptions are posted for easy reference. William T. McDermott, Assistant Administrator. [FR Doc. 2021-06689 Filed 4-22-21; 8:45 am] BILLING CODE 4410-09-C --- Source: Frix Law Library, https://www.frixlaw.com/law-library/documents/fr%3A2021-06689. Public record. Not legal advice.